(353) Controlled Release of Gemcitabine with Partially Molecular Imprinted Microspheres for Cancer Therapy
Introduction: Controlled release of drugs is crucial for enhancing therapeutic efficacy especially in anticancer treatments where precise dosing plays a crucial role in patient outcomes. This study introduces partial molecular imprinting (PMI) to control solubility-dependent release by generating nanocavities within a polymer matrix, enhancing drug delivery stability. Although PMI is an emerging concept, its ability to modulate drug crystallinity and release kinetics in biomaterial-based systems shows great promise for advancing targeted cancer therapies and medical technology applications
Learning Objectives:
Upon completion, participants will be able to define controlled drug release systems
Upon completion, participants will be able to describe PMI strategies for targeted drug delivery
Upon completion, participants will be able to describe the effectiveness of PMI in drug delivery
KALADHAR KAMALASANAN, Ph.D in Biomedical Engineering, Post-doc in University of Pittsburgh – Professor, Department of Pharmaceutics, AMRITA SCHOOL OF PHARMACY, AMRITA INSTITUTE OF MEDICAL SCIENCE, AMRITA VISHWA VIDYAPEETHAM
